Mapping large numbers of results may take a few moments.
Search Results
Showing 501 - 537 of 537 results found.
| Company | Activity | Company Description | Location | |
|---|---|---|---|---|
 |
Company UCB Biosciences Inc. | Activity: Research and Development | Company Description UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis. | Location Morrisville |
| |
Company Ummino | Activity: Research and Development | Company Description Ummino is developing technology that uses precision fermentation to fortify food and beverage products and restore and repair the microbiome. | Location Raleigh |
| |
Company United Therapeutics Corp. (RTP HQ) | Activity: Research and Development | Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. | Location Research Triangle Park |
| |
Company UPL (Cary) | Activity: Research and Development | Company Description UPL develops, manufactures and provides agricultural solutions, including biological, crop protection, seed treatment and post-harvest technologies covering the entire agricultural value chain. | Location Cary |
| |
Company UPL OpenAg Center (RTP) | Activity: Research and Development | Company Description UPL develops, manufactures and provides agricultural solutions across the agricultural value chain. The OpenAg Center contains climate-controlled greenhouses and laboratories and will partner with collaborating companies to develop resistance products. | Location Research Triangle Park |
| |
Company Upstream Biotechnology Inc. | Activity: Research and Development | Company Description Upstream Biotechnology uses patented technology to develop broad-spectrum disease resistant crops to eliminate pesticide use, reduce production cost and increase crop yield. | Location Sanford |
| |
Company URO-1 Inc. | Activity: Research and Development | Company Description URO-1 develops breakthrough products for office procedures for urology and urogynecology, which improve clinical outcomes, enhance patient experience and increase procedure efficiency. | Location Greensboro |
| |
Company ValanBio Therapeutics Inc. | Activity: Research and Development | Company Description Valanbio Therapeutics is an early-stage anti-infectives company. Valanbio is developing novel antibiotics for Gram-negative organisms. | Location Durham |
| |
Company Vascular BioSciences Inc. | Activity: Research and Development | Company Description Vascular BioSciences is a biopharmaceutical company developing solutions for difficult-to-treat cardiovascular and inflammatory diseases. | Location Durham |
| |
Company Vast Therapeutics | Activity: Research and Development | Company Description Vast Therapeutics uses a nitric oxide technology for the treatment of cystic fibrosis and other respiratory diseases. | Location Durham |
| |
Company Velo Bio LLC | Activity: Research and Development | Company Description Velo Bio is developing an orphan drug for the treatment of severe preeclampsia in pregnant women. | Location Morrisville |
| |
Company Veloxis Pharmaceuticals Inc | Activity: Sales and Operations | Company Description Veloxis Pharmaceuticals is focused on the global development and commercialization of medications utilized by transplant patients and by patients with serious related diseases. | Location Cary |
| |
Company Verb Biotics LLC | Activity: Research and Development | Company Description Verb Biotics identifies and designs new strains of probiotics and postbiotics for nutrition, health and wellness. | Location Durham |
| |
Company Verdesian Life Sciences LLC (Cary) | Activity: Research and Development | Company Description Verdesian Life Sciences develops agricultural products with a focus in plant health, inoculants, seed treatment and nutrition. | Location Cary |
| |
Company Verdesian Life Sciences LLC (RTP) | Activity: Research and Development | Company Description Verdesian Life Sciences' lab in RTP focuses on the exploration of emerging and disruptive technologies to improve plant nutrient use efficacy, agriculture productivity and environmental sustainability. | Location Research Triangle Park |
| |
Company Verinetics Inc. | Activity: Research and Development | Company Description Verinetics is commercializing platform technology that makes dispensing controlled substance pharmaceuticals safer for patients and their providers. | Location Research Triangle Park |
| |
Company Verona Pharma Inc. | Activity: Research and Development | Company Description Verona Pharma is a clinical stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of respiratory diseases such as chronic obstructive pulmonary fibrosis (COPD) and cystic fibrosis (CF). | Location Raleigh |
| |
Company Vestaron Corp. | Activity: Sales and Operations | Company Description Vestaron develops and manufactures peptide-based biopesticides. | Location Durham |
| |
Company Viamer Biosciences | Activity: Research and Development | Company Description Viamer Biosciences develops advanced and proprietary biomaterials for controlled release drug delivery and regenerative medical devices. | Location Durham |
| |
Company ViiV Healthcare | Activity: Research and Development | Company Description ViiV Healthcare, a joint venture established by GSK and Pfizer, researches and develops new HIV medicines and advances care for people living with HIV. | Location Durham |
| |
Company ViroKyne Therapeutics LLC | Activity: Research and Development | Company Description Virokyne is developing novel therapies for the treatment of viral diseases. | Location Durham |
| |
Company Vital Plan Inc. | Activity: Research and Development | Company Description Vital Plan formulates and produces natural supplements and herbal therapies that support immune health, microbiome balance, and healthy aging. | Location Raleigh |
| |
Company VitalEphX | Activity: Research and Development | Company Description VitalEphX develops therapeutics that preserve tissue viability and performance following myocardial infarction. | Location Greenville |
| |
Company VitriStor LLC | Activity: Research and Development | Company Description VitriStor is developing technologies to produce large quantities of hepatocytes (liver cells) on demand for cell therapy, regenerative medicine and pharmaceutical applications. | Location Charlotte |
| |
Company Vizma.AI | Activity: Research and Development | Company Description Vizma.AI provides diagnostic molecular insights to oncologists, cardiologists and neurologists with non-invasive and patient-centric technology. | Location Chapel Hill |
| |
Company Vogenx Inc. | Activity: Research and Development | Company Description Vogenx is a clinical stage pharmaceutical company developing a molecule to address post-bariatric hypoglycemia. | Location Durham |
| |
Company vTv Therapeutics LLC | Activity: Research and Development | Company Description vTv Therapeutics is a clinical-stage biopharmaceutical company developing orally administered small molecule drug candidates to fill significant unmet medical needs in Alzheimer's disease (AD), diabetes and inflammatory disorders. | Location High Point |
| |
Company Xilis Inc. | Activity: Research and Development | Company Description Xilis is developing microfluidic droplet-based patient-derived organoid (MDPDO) technology to guide precision therapy for cancer patients and accelerate drug discovery. | Location Durham |
| |
Company Xollent Biotech Inc. | Activity: Research and Development | Company Description Xollent Biotech is developing a therapeutic to treat cardiovascular disease based on exosome-secreting cells. | Location Cary |
| |
Company Xona Microfluidics Inc. | Activity: Research and Development | Company Description Xona Microfluidics develops and manufactures microfluidic platforms for neuroscience research. | Location Research Triangle Park |
| |
Company Xsome Biotech Inc. | Activity: Research and Development | Company Description Xsome Biotech is developing inhalable vaccines using a lung-derived exosome. | Location Cary |
| |
Company Zarbio LLC | Activity: Research and Development | Company Description Zarbio develops pathophysiology-based treatments for neurodegenerative diseases such as Alzheimer's disease. | Location Chapel Hill |
| |
Company Zinfandel Pharmaceuticals Inc. | Activity: Research and Development | Company Description Zinfandel Pharmaceuticals uses pharmacogenetics to improve prediction of risk for Alzheimer’s disease and facilitate the development of effective therapies. | Location Chapel Hill |
| |
Company Zoion Pharma Inc. | Activity: Research and Development | Company Description Zoion Pharma develops drugs for veterinary disorders. Zoion's lead product is an epithelial sodium channel blocker compound to treat canine keratoconjunctivitis sicca (KCS) or dry eye. | Location Raleigh |
| |
Company ZY Therapeutics Inc. | Activity: Research and Development | Company Description ZY Therapeutics is developing a drug delivery platform for cancer therapeutics using nanotechnology. | Location Research Triangle Park |
| |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham |
| |
Company Zymtronix Inc. | Activity: Research and Development | Company Description Zymtronix provides technology that can enable and improve any biocatalytic reaction involving single enzymes or cell-free systems of multiple enzymes. Zymtronix offers solutions for various industries, including agriculture, life sciences, and ingredients. | Location Research Triangle Park |